Entera Bio Ltd. Warrant
ENTXW
ENTXW was delisted on the 27th of June, 2023.
3 hedge funds and large institutions have $24K invested in Entera Bio Ltd. Warrant in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
85% less capital invested
Capital invested by funds: $160K → $24K (-$136K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$113K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$278 |
ENTXW Hedge Fund Activity: Q3 2021 in Review
3 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q3 2021, worth a combined $24K — down 85% from $160K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Ionic Capital Management, exiting entirely with an estimated $113K sold.
- 3 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q3 2021, down from 4 in Q2 2021.
- Funds reported $24K of Entera Bio Ltd. Warrant stock for Q3 2021, down 85% quarter-over-quarter.
- 0 funds opened new Entera Bio Ltd. Warrant positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest Entera Bio Ltd. Warrant seller in Q3 2021 was Ionic Capital Management, an estimated $113K sold.
Based on aggregated 13F filings for Q3 2021.